Long COVID Atlas
Text Theme
Note

Neuroinflammation here is inferred from imaging and tissue studies, not from a test your clinic can run. The diagram is a teaching schematic, not a scan.

Mechanism · Neurology

Neuroinflammation

The brain runs its own immune patrol. In long COVID that patrol can stay switched on long after the infection clears, producing a low, persistent inflammation inside the brain. It is one of the most cited explanations for the neurological side of long COVID.

Short version: the brain's immune cells, the microglia, can stay activated after COVID, producing inflammation inside the brain that fits brain fog and related symptoms.

The brain has its own immune system

The brain is patrolled by microglia, immune cells that normally rest quietly. When they sense danger they activate, releasing inflammatory signals. Useful in a real emergency; harmful when the alarm will not switch off. That stuck-on state is neuroinflammation.1

Why thinking feels slow bloodstream: lasting inflammation, clotting signals blood-brain barrier, now leaky microglia (brain immune cells) switch on brain fog: slow recall, poor focus,word-finding trouble
Brain fog is not laziness or anxiety. Lasting inflammation in the blood, together with a brain barrier that has become leaky, lets inflammatory signals reach brain tissue and switches on the brain's own immune cells, the microglia. That low-grade neuroinflammation is what slows recall, focus, and word-finding.

How COVID sets it off

Two routes are described. Inflammatory signals and viral fragments, including the spike protein, can reach the brain when the blood-brain barrier is leaky, and the resulting microglial activation has been seen directly in tissue studies.1, 2

moderate

Why it matters for symptoms

Activated microglia disturb the chemistry that neurons rely on, which fits brain fog, unrefreshing sleep, and the way mental effort can trigger a crash. It connects the brain symptoms to the same inflammation seen elsewhere in the body.3

Where treatment stands

No anti-inflammatory drug is proven to calm long COVID neuroinflammation, and self-medicating carries risks. Pacing mental load remains the dependable tool while trials continue.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • How much of the inflammation is driven by viral fragments versus the body's own response.
  • Whether it is reversible, and over what timeframe.
  • Whether calming microglia would relieve symptoms in people, which no trial has shown.
  • How to measure it without specialized research imaging.
  • How it relates to the longer-term questions about brain aging.

References

Every reference is free to read in full.

  1. SARS-CoV-2, the blood-brain barrier, and neuroinflammation (S1 protein crosses the barrier).
  2. Cerebromicrovascular mechanisms and microglial activation in long COVID.
  3. Blood-brain barrier disruption and inflammation in long COVID cognitive impairment.

Associated topics